|
2025
|
Invention
|
Antibody molecules.
The present invention provides pharmaceutical compositions comprising second... |
|
|
Invention
|
Cross-species anti-latent tgf-beta 1 antibodies and methods of use.
The objective of the inventi... |
|
|
Invention
|
Method for synthesizing peptides in cell-free translation system.
An objective of the present in... |
|
|
Invention
|
Anti-hla-dq2.5 antibody.
The antibodies of the present invention have specific binding activity ... |
|
|
Invention
|
Antibody substituting for function of blood coagulation factor viii.
The present inventors produ... |
|
|
Invention
|
High concentration antibody-containing liquid formulation.
The problem to be solved is to provid... |
|
|
Invention
|
Treatment and prevention of muscular dystrophy and its related diseases or disorders with satrali... |
|
|
Invention
|
O-substituted serine derivative production method.
It was discovered that a cyclic sulfamidate c... |
|
|
Invention
|
Methods for producing cyclic compounds comprising n-substituted amino acid residues.
The present... |
|
|
Invention
|
Method for calculating relative ratio (sij) of reaction rate constant between trinucleotides, and... |
|
|
Invention
|
Peptide, surfactant having sugar fatty acid ester structure, and pharmaceutical composition conta... |
|
|
Invention
|
Composition for treating il-6-related diseases.
The present invention provides a pharmaceutical ... |
|
|
Invention
|
Method for predicting therapeutic effect of combination therapy of il-6 inhibitor and chemotherap... |
|
|
Invention
|
Protein purification with protein l.
The invention provides methods of purifying and/or producin... |
|
|
Invention
|
Methods of treating myasthenia gravis. The present disclosure provides methods for treating patie... |
|
|
Invention
|
Method for producing peptide compound having ring structure. The present invention provides a nov... |
|
|
Invention
|
Anti-dll3 antibody.
An antibody which binds to DLL3 protein, composition containing the antibody... |
|
|
Invention
|
Use of myt1 inhibitor. The present invention provides a pharmaceutical composition comprising, as... |
|
|
Invention
|
Cyclic compound having selective kras inhibitory effect on hras and nras.
Cyclic compounds that ... |
|
|
Invention
|
Method for producing sulfonamide compound using sulfonyl triazolium. The present invention provid... |
|
|
Invention
|
Method for producing sulfonamide compound using 4-aminopyridine derivative. The present invention... |
|
|
Invention
|
Information processing system, information processing method, and information processing program.... |
|
|
Invention
|
Cd3-targeting antigen-binding molecule with improved stability. The present disclosure provides a... |
|
|
Invention
|
Cell culture medium.
Provided are a method, an agent, or the like for improving the stability of... |
|
|
Invention
|
Method for measuring cellular uptake of molecules.
The present invention provides a method for m... |
|
|
Invention
|
Antigen-binding molecules that bind pdgf-b and pdgf-d, and methods of use. The present invention ... |
|
2024
|
Invention
|
Method for producing antibodies. The present application provides a method for enabling efficient... |
|
|
Invention
|
Method for producing peptide compound using stand-alone-type condensing agent. Provided is a meth... |
|
|
Invention
|
Method for producing peptide compound using two or more additives. Provided is a method for produ... |
|
|
Invention
|
Method for producing antibodies. A method for producing cells that produce multispecific binding ... |
|
|
Invention
|
Dosage and administration regimen for the treatment or prevention of guillan-barre syndrome by th... |
|
|
Invention
|
Dosage and administration regimen for the treatment or prevention of guillan-barré syndrome by th... |
|
|
Invention
|
Cytotoxicity-inducing therapeutic agent.
Novel multispecific antigen-binding molecules maintaini... |
|
|
Invention
|
Amorphous form of tetracyclic compound.
An amorphous form of 9-ethyl-6,6-dimethyl-8-(4-morpholin... |
|
|
Invention
|
Peptide capable of being analyzed and/or evaluated by mass spectrometry and use thereof. The pres... |
|
|
Invention
|
Cell culture method and system. Provided is a culture method for maintaining the productivity of ... |
|
|
G/S
|
Pharmaceutical preparations. Providing education and training services in the medical
field. Pro... |
|
2023
|
Invention
|
Method for producing antibody. The present application provides a method with which it is possibl... |
|
|
Invention
|
Novel promoter. Provided is a novel promoter for expressing a recombinant protein with a mammalia... |
|
|
Invention
|
Information processing system, information processing method, information processing program, and... |
|
|
Invention
|
Pharmaceutical composition for treating or preventing cystic disease.
The present invention prov... |
|
|
Invention
|
Title of invention: pharmaceutical-preparation-containing syringe equipped with filter.
An objec... |
|
|
Invention
|
Pharmaceutical for treating or preventing cancer.
The present invention provides a drug for trea... |
|
|
Invention
|
Composition containing peptide compound for use with surfactant.
The present invention relates t... |
|
|
Invention
|
Production method for peptide compound.
A method for producing a peptide compound by a solid pha... |
|
|
Invention
|
Chemical solution enclosing device and chemical solution enclosing method.
A chemical solution e... |
|
2022
|
Invention
|
Method for producing n-alkyl amino acid and peptide including n-alkyl amino acid.
Provided is a ... |
|
|
Invention
|
Composition including peptide compound and surfactant.
The present invention relates to a compos... |
|
|
Invention
|
Method of forming bond by coupling reaction.
The present invention provides a method of producin... |
|
|
Invention
|
Pulmonary arterial hypertension patient selection method and biomarker.
The present invention re... |
|
2021
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or ... |
|
|
G/S
|
Pharmaceutical research and development services and providing information about medical and scie... |
|
2020
|
G/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives, cells or genes tha... |
|
2019
|
G/S
|
Pharmaceutical research and development services and
providing information about medical and sci... |
|
|
G/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives; cells or genes tha... |
|
2017
|
G/S
|
Providing educational classes, seminars, workshops, symposiums and conferences and training servi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neuromyelitis optica spectrum disorder |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment of hemophilia A. |
|
|
G/S
|
[ Pharmaceutical oncology preparations ] Providing educational classes, seminars, workshops, symp... |
|
|
G/S
|
pharmaceutical preparations for the treatment of Hemophilia A |
|
2013
|
G/S
|
pharmaceutical preparation, namely, an anti-cancer drug |
|
2012
|
G/S
|
Injection devices for medical purposes. |
|
|
G/S
|
injection devices for medical purposes |
